CQENS Technologies Inc.

Pharmaceutical Preparations·MINNEAPOLIS, MN

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CQENS Technologies Inc.

Pharmaceutical Preparations·MINNEAPOLIS, MN

CEO

Chong Alexander C.

CFO

Markes Daniel

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

$70,200

FY 2024

Net Income

-$4.3M

FY 2024

EPS (Diluted)

-$0.16

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$350,565

FY 2024

Total Debt

$50,000

FY 2020

Net Cash

$300,565

FY 2020

Enterprise Value

—

Debt / EBITDA

-4.3x

FY 2024

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

$70,200

FY 2024

Net Income

-$4.3M

FY 2024

EPS (Diluted)

-$0.16

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$350,565

FY 2024

Total Debt

$50,000

FY 2020

Net Cash

$300,565

FY 2020

Enterprise Value

—

Debt / EBITDA

-4.3x

FY 2024

EV / EBITDA

—

Employees

—

CEO

Chong Alexander C.

CFO

Markes Daniel